Colorectal cancer screening

Current Oncology Reports

Volumn 11, Issue 6, 2009, Pages 482-489

  Nelson, R Scott ^a   Thorson, Alan G ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ANAMNESIS; BARIUM ENEMA; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST BENEFIT ANALYSIS; DNA DETERMINATION; ENTERITIS; FALSE POSITIVE RESULT; FAMILY HISTORY; FECES ANALYSIS; GENETIC COUNSELING; GENETIC RISK; HUMAN; ILEOSTOMY; IMMUNOHISTOCHEMISTRY; OCCULT BLOOD; PROCTOCOLECTOMY; RADIATION HAZARD; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY;

ADENOMA; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; HUMANS; MALE; MASS SCREENING; UNITED STATES;

EID: 70350164542     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-009-0065-8     Document Type: Review

References (51)

1. Jemal A, Siegal R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
2. Jemal A, Thun MJ, Ries LA, et al.: Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008, 100:1672-1694.
3. SEER Cancer Statistics Review, 1975-2004. Edited by Ries L, Melbert D, Krapcho M, et al.: Bethesda, MD: National Cancer Institute; 2007.
4. Winawer SE, Zauber AG, Stewart E, O'Brien MJ: The natural history of colorectal cancer. Opportunities for intervention. Cancer 1991, 67:1143-1149.
5. O'Brien MJ, Winawer SJ, Zauber AG, et al.: The National Polyps Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990, 98:371-379.
6. Bond JH: Colon polyps and cancer. Endoscopy 2003, 35: 27-35.
7. Winawer SJ, Fletcher RH, Miller L, et al.: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997, 112:594-642.
8. Winawer SJ: Natural history of colorectal cancer. Am J Med 1999, 106:3S-6S.
9. Seff LC, Nadel MR, Klabunde CN, Thompson T, et al.: Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004, 100:2093-2103.
10. Allison JE, Tekawa IS, Ransom LJ, et al.: A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 1996, 334:155-159.
11. Ransohoff DF, Lang CA: Screening for colorectal cancer with the fecal occult blood test, a background paper. American College of Physicians. Ann Intern Med 1997, 126:811-822.
12. Hardcastle JD, Chamberlain JO, Robinson MH, et al.: Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
13. Kronborg O, Fenger C, Olsen J, et al.: Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467-1471.
14. Wilson JG, Junger G: Principals and Practice of Screening for Disease. Geneva, Switzerland: World Health Organization; 1968.
15. Levi Z, Rozen P, Hazazi R, et al.: A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007, 146:244-245.
16. Allison JE, Sakoda LC, Levin TR, et al.: Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. J Natl Cancer Inst 2007, 99:1462-1470.
17. Gopalswamy N, Stelling HP, Markert RJ, et al.: A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated. Arch Fam Med 1994, 3:1043-1048.
18. Wong BC, Wong WM, Cheung KL, et al.: A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 2003, 18:941-946.
19. Smith A, Young GP, Cole SR, et al.: Comparison of a crushsampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006, 107:2151-2159.
20. Kutzner N, Hoffmann I, Kinke C, et al.: Non-invasive detection of colorectal tumors by the combined application of molecular diagnosis and the faecal occult blood test. Cancer Lett 2005, 229:33-41.
21. Levin B, Lieberman DA, McFarland B, et al.: Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force of Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008, 58:130-160.
22. Selby JV, Friedman GD, Quesenberry CP, et al.: A case control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992, 326:653-657.
23. Newcomb PA, Norgleet RG, Storer BE, et al.: Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992, 84:1572-1575.
24. Winawer SJ, Fletcher RH, Miller L, et al.: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997, 112:594-642.
25. Byers T, Levin B, Rothenberger D, et al.: American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 1997, 47:154-160.
26. Winawer S, Fletcher R, Rex D, et al.: Colorectal cancer screening and surveillance: Clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003, 124:544-560.
27. Kelvin FM, Gardiner R, Vas W, et al.: Barium enema and endoscopy for the detection of colorectal neoplasia: Sensitivity, specificity, complications, and its determinants. Clin Radiol 2001, 56:401-409.
28. Thorpe CD, Grayson DJ, Wingfield PB: Detection of carcinoma of the colon and rectum by air contrast enema. Surg Gynecol Obstet 1981, 152:307-309.
29. Fork FT, Lindstrom C, Ekelund G: Double contrast examination in carcinoma of the colon and rectum. A prospective clinical series. Acta Radiol Diagn (Stockh) 1983, 24:177-188.
30. Johnson CD, Carlson HC, Taylor WF, et al.: Barium enemas of carcinoma of the colon: Sensitivity of double- and single-contrast studies. AJR Am J Roentgenol 1983, 140:1143-1149.
31. Winawer SJ, Steart ET, Zauber AG, et al.: A comparison of colonoscopy and double contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 2000, 342:1766-1772.
32. Farrar WD, Sawhney MS, Nelson DB, et al.: Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hpatol 2006, 4:1259-1264.
33. Pickhardt PG, Nugent PA, Mysliwiec PA, et al.: Location of adenomas missed by optical colonoscopy. Ann Intern Med 2004, 141:352-359.
34. Seeff LC, Richards TB, Shapiro JA, et al.: How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology 2004, 127:1670-1677.
35. Winawer SJ, Zuaber AG, Ho MN, et al.: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329:1977-1981.
36. Thiis-Evensen E, Hoff GS, Sauar J, et al.: Population-based surveillance by colonoscopy: Effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999, 34:414-420.
37. Muller AD, Sonnenberg A: Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995, 123:904-910.
38. Rex DK, Cutler CS, Lemmel GT, et al.: Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997, 112:24-28.
39. Bresslet B, Paszat LF, Vinden C, et al.: Risk of perforation after colonoscopy and sigmoidoscopy: A population-based study. J Natl Cancer Inst 2003, 95:230-236.
40. Gatto NM, Frucht H, Sundararajan V, et al.: Risk of perforation after colonoscopy and sigmoidoscopy: A population-based study. J Natl Cancer Inst 2003, 95:230-236.
41. Winawer SJ, Zauber AG, Fletcher RH, et al.: Guidelines for colonoscopy surveillance after polypectomy: A consensus update by the US Multi-society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 2006, 56:143-159.
42. Winawer SJ, Zauber AG, Gerdes H, et al.: Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996, 334:82-87.
43. Burt RQ, Barthel JS, David DS, et al.: National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology; Colorectal Cancer Screening. Version 2, 2008.
44. Zauber AG, Landsdorp-Vogelaar I, Knudsen AB, et al.: Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008, 149:659-669.
45. Surveillance Epidemiology and End Results: SEER Cancer Statistics Review, 1975-2000. Edited by Rise LAG, Eisner MP, Kosary CL, et al. Bethesda, MD: National Cancer Institute. Available at http://seer.cancer.gov/csr/1975_2000. Accessed August 2009.
46. Nelson RL, Persky V, Turyk M: Carcinoma in of the colorectum: SEER trends by race, gender, and total colorectal cancer. J Surg Oncol 1999, 71:123-129.
47. Agrawal S, Bhypinderjit A, Bhutani MS, et al.: Colorectal cancer in African Americans. Am J Gastroenterol 2005, 100:515-523.
48. Klabunde CN, Frame PS, Meadow A, et al.: A national survey of primary care physicians' colorectal screening recommendations and practices. Prev Med 2003, 36:352-362.
49. Meissner HI, Breen N, Klabunde CN, et al.: Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006, 15:389-394.
50. Breen N, Wagener DK, Brown ML, et al.: Progress in cancer screening over a decade: Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001, 93:1704-1713.
51. Centers for Disease Control and Prevention (CDC): Use of colorectal cancer tests - United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep, 2008: 57:253-258.